{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:02:50Z","timestamp":1771002170294,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:p>\n                    (\n                    <jats:italic>Headache<\/jats:italic>\n                    2011;51:544\u2010553)\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Background.\u2014<\/jats:bold>\n                    Calcitonin gene\u2010related peptide (CGRP) is a key molecule in migraine pathogenesis. Intravenous CGRP triggers migraine\u2010like attacks in patients with migraine with aura and without aura. In contrast, patients with familial hemiplegic migraine (FHM) with known mutations did not report more migraine\u2010like attacks compared to controls. Whether CGRP triggers migraine\u2010like attacks in FHM patients without known mutations is unknown.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective.\u2014<\/jats:bold>\n                    In the present study we therefore examined the migraine\u2010inducing effect of CGRP in FHM patients without known mutations and healthy controls.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods and design.\u2014<\/jats:bold>\n                    Eleven patients suffering from FHM without known mutations and 11 controls received an intravenous infusion of 1.5\u2003\n                    <jats:italic>\u00b5<\/jats:italic>\n                    g\/minute CGRP over 20\u2003minutes. The study design was a balanced and controlled provocation study. Headache and other migraine symptoms were scored for 1 hour and self\u2010recorded hourly thereafter until 13\u2010hour postinfusion.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.\u2014<\/jats:bold>\n                    We found no difference in the incidence of migraine\u2010like attacks between the 2 groups, with 9% (1 of 11) of patients and 0% (0 of 10) of controls reporting migraine\u2010like headache (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20031.00). CGRP infusion did not induce aura symptoms in any of the participants. There was no difference in the incidence of CGRP\u2010induced delayed headaches between the groups (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u2003.18).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.\u2014<\/jats:bold>\n                    In contrast to patients suffering from migraine with aura and without aura, CGRP infusion did not induce more migraine\u2010like attacks in FHM patients without known mutations compared to controls. It seems that the majority of FHM patients with and without known mutation display no sensitivity to CGRP signaling compared to common types of migraine.\n                  <\/jats:p>","DOI":"10.1111\/j.1526-4610.2011.01861.x","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T16:26:10Z","timestamp":1301675170000},"page":"544-553","source":"Crossref","is-referenced-by-count":53,"title":["Calcitonin Gene\u2010Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine"],"prefix":"10.1111","volume":"51","author":[{"given":"Jakob M.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise L.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.09.003"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030505"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000286940.29755.61"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410368444"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00310.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000325482.64106.3f"},{"issue":"1","key":"e_1_2_7_8_2","first-page":"9","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia."},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81373-2"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66786-4"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1081"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl334"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420610"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1996.1603153.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(89)90067-5"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01172.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cff79d"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7013.1145"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6719.230"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f9626a"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230214"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq224"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp168"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01559.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01542.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2000.00094.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450103"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410090406"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.071582498"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1992.tb09451.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20035"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(04)00085-6"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21815"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2009.01.027"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-5-34"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.652"},{"key":"e_1_2_7_37_2","first-page":"264","article-title":"A potential preclinical migraine model: CGRP\u2010sensitized mice","volume":"1","author":"Russo AF","year":"2009","journal-title":"Mol Cell Pharmacol."},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-4-12"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705456"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.274.6.H1979"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01864.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2011.01861.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2011.01861.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:43:54Z","timestamp":1762087434000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2011.01861.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1526-4610.2011.01861.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2011.01861.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}